Myasthenia Gravis

  • E. Facco
  • F. Gallo
  • S. M. Volpin
Conference paper


Myasthenia Gravis (MG) is an autoimmune disease, resulting from the production of antibodies against the acetylcholine receptors (AChRs) of the endplate. The essential clinical feature of MG is a fluctuant weakness of voluntary muscles, mostly those innervated by cranial nerves; its incidence is about 1 in every 20,000 adults and is age- and sex-related, with one peak in the second and third decades affecting mostly women and a second peak in the sixth and seventh decades affecting mostly men [1].


Acetylcholine Receptor Neuromuscular Junction Neuromuscular Transmission Epidural Morphine Myasthenic Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Baraka A (1992) Anaesthesia and myasthenia gravis. Can J Anaesth 39:476–466PubMedCrossRefGoogle Scholar
  2. 2.
    Long RR (1991) Myasthenia gravis in the intensive care unit. In: Rippe JM, Irwin RS, Alpert J et al (ed) Intensive care medicine. Little, Brown and Company, Boston Toronto London, pp 1596–1601Google Scholar
  3. 3.
    Grob D, Arsura EL, Brunner NG et al (1987) The course of myasthenia gravis and therapies affecting outcome. Ann NY Acad Sci 505:472–499PubMedCrossRefGoogle Scholar
  4. 4.
    Derdak S (1988) Myasthenia gravis. In: Civetta JM, Taylor RW, Kyrby RR (ed) Critical care. JB Lippincott Company, Philadelphia, pp 1257–1260Google Scholar
  5. 5.
    Engel AG (1987) Myasthenia gravis and other disorders of neuromuscular transmission. In: Braunwald E, Isselbacher KJ, Petersdorf RG et al (ed) Harrison’s Principles of internal medicine. McGraw-Hill Book Company, New York, pp 2079–2082Google Scholar
  6. 6.
    Osserman KE, Genkins G (1971) Studies on myasthenia gravis. Review of a twenty-year experience in over 1200 patients. M Sinai J M 38:497–537Google Scholar
  7. 7.
    Drachman DB (1994) Myasthenia gravis. N Engl J Med 330:1797–1810PubMedCrossRefGoogle Scholar
  8. 8.
    Drachman DB (1978) Myasthenia gravis. N Engl J Med 298:136–142PubMedCrossRefGoogle Scholar
  9. 9.
    Lindstrom JM, Seybold ME, Lenon VA et al (1976) Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 26: 1054–1059PubMedCrossRefGoogle Scholar
  10. 10.
    Pestronk A, Drachman DB, Self SG (1985) Measurement of junctional acetylcoline receptors in myasthenia gravis: clinical correlates. Muscle Nerve 8:245–251PubMedCrossRefGoogle Scholar
  11. 11.
    Engel AG, Tsujihata M, Lindstrom JM et al (1976) The motor end-plate in myasthenia gravis and in experimental autoimmune myasthenia gravis: a quantitative ultrastructural study. Ann NY Acad Sci 274:60–79PubMedCrossRefGoogle Scholar
  12. 12.
    Bowman WC (1980) Prejunctional and postjunctional cholinoceptors at the neuromuscular junction. Anesth Analg 59:935–943PubMedCrossRefGoogle Scholar
  13. 13.
    Woolf AL (1966) Morphology of the myasthenic neuromuscular junction. Ann NY Acad Sci 135:33–58CrossRefGoogle Scholar
  14. 14.
    Sanders DB (1987) The electrodiagnosis of myasthenia gravis. Ann NY Acad Sci 505: 539–555PubMedCrossRefGoogle Scholar
  15. 15.
    Vincent A, Newsom-Davis J (1985) Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 48:1246–1252PubMedCrossRefGoogle Scholar
  16. 16.
    Drachman DB, De Silva S, Ramsay D et al (1987) Humoral pathogenesis of myasthenia gravis. Ann NY Acad Sci 505:90–104PubMedCrossRefGoogle Scholar
  17. 17.
    Toyka KV, Drachman DB, Griffin DE et al (1977) Myasthenia gravis: study of humoral immune mechanisms by passive transfer to mice. N Engl J Med 296:125–131PubMedCrossRefGoogle Scholar
  18. 18.
    Lambert EH, Lindstrom JM, Lennon VA (1976) End-plate potentials in experimental autoimmune myasthenia gravis in rats. Ann NY Acad Sci 274:300–318PubMedCrossRefGoogle Scholar
  19. 19.
    Penn AS, Chang HW, Lovelace RE et al (1976) Antibodies to acetylcholine receptors in rabbits: immunochemical and electrophisiological studies. Ann NY Acad Sci 274:354–376PubMedCrossRefGoogle Scholar
  20. 20.
    Drachman DB, Adams RN, Josifek LF et al (1982) Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med 307: 769–775PubMedCrossRefGoogle Scholar
  21. 21.
    Vincent A, Whiting PJ, Schluep M et al (1987) Antibody heterogeneity and specifity in myasthenia gravis. Ann NY Acad Sci 505:326–332CrossRefGoogle Scholar
  22. 22.
    Howard FM jr, Lennon VA, Finley J et al (1987) Clinical correlation of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Ann NY Acad Sci 505:526–538PubMedCrossRefGoogle Scholar
  23. 23.
    Mossman S, Vincent A, Newsom-Davis J (1986) Myasthenia gravis without acetylcholine receptor antibody: a distinct disease entity. Lancet 1:116–119PubMedCrossRefGoogle Scholar
  24. 24.
    Brooks EB, Pachner AR, Drachman DB et al (1990) A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H-1 cells: positive results in “antibody negative” myasthenia gravis. J Neuroimmunol 28:83–93PubMedCrossRefGoogle Scholar
  25. 25.
    Yamamoto T, Vincent A, Ciulla TA et al (1991) Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM. Ann Neurol 30:550–557PubMedCrossRefGoogle Scholar
  26. 26.
    Berrih-Aknin S, Morel E, Raimond F et al (1987) The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases. Ann NY Acad Sci 505: 50–70PubMedCrossRefGoogle Scholar
  27. 27.
    Moiola L, Protti MP, Manfredi AA et al (1993) T- helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis. Ann NY Acad Sci 505: 198–218CrossRefGoogle Scholar
  28. 28.
    Ozdemir C, Young RR (1976) The results to be expected from electrical testing in the diagnosis of myasthenia gravis. Ann NY Acad Sci 274:203–222PubMedCrossRefGoogle Scholar
  29. 29.
    Kim YI (1987) Lambert-Eaton myasthenic syndrome: evidence for calcium channel blockade. Ann NY Acad Sci 505:377–379PubMedCrossRefGoogle Scholar
  30. 30.
    Grob D, Brunner NG, Namba T (1981) The natural course of myasthenia gravis and effect of therapeutic measures. Ann NY Acad Sci 377:652–669PubMedCrossRefGoogle Scholar
  31. 31.
    Kirsch JR, Diringer NM, Borel CO et al (1991) Preoperative lumbar epidural morphine improves postoperative analgesia and ventilatory function after transsternal thymectomy in patients with myasthenia gravis. Crit Care Med 19:1474–1479PubMedCrossRefGoogle Scholar
  32. 32.
    Kao I, Drachman DB (1977) Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. Science 195:74–75PubMedCrossRefGoogle Scholar
  33. 33.
    Wheatley LM, Urso D, Tumas K et al (1992) Molecular evidence for the expression of nicotinic acetylcholine receptor a-chain in mouse thymus. J Immunol 148:3105–3109PubMedGoogle Scholar
  34. 34.
    Johns TR (1987) Long-term corticosteroid treatment of myasthenia gravis. Ann NY Acad Sci 505:568–583PubMedCrossRefGoogle Scholar
  35. 35.
    Van Wilgenburg H (1979) The effect of prednisolone on neuromuscular transmission in the rat diaphragm. Eur J Pharmacol 55:355–361PubMedCrossRefGoogle Scholar
  36. 36.
    Tindall RSA, Phillips JT, Rollins JA et al (1993) A clinical therapeutic trial of cyclosporine in myasthenia gravis. Ann NY Acad Sci 681:539–551PubMedCrossRefGoogle Scholar
  37. 37.
    Schalke BCG, Kappos L, Rohrbach E et al (1988) Cyclosporine A vs azathioprine in the treatment of myasthenia gravis: final results of a randomized, controlled double blind clinical trial. Neurology 38[Suppl 1]:135.Google Scholar
  38. 38.
    Pinching AJ, Peters DK, Newsom-Davis J (1976) Remission of myasthenia gravis following plasma-exchange. Lancet 2:1373–1376PubMedCrossRefGoogle Scholar
  39. 39.
    Keesey J, Buffklin D, Kebo D et al (1981) Plasma exchange alone as therapy for myasthenia gravis. Ann NY Acad Sci 377:729–743PubMedCrossRefGoogle Scholar
  40. 40.
    Reimann PM, Mason PD (1990) Plasmapheresis: technique and complications. Intensive Care Med 16:3–10PubMedCrossRefGoogle Scholar
  41. 41.
    Genkins G, Sivak M, Tartter P (1993) Treatment strategies in myasthenia gravis. Ann NY Acad Sci 681:603–608PubMedCrossRefGoogle Scholar
  42. 42.
    Drachman DB, McIntosh KR, Reim J et al (1993) Strategies for treatment of myasthenia gravis. Ann NY Acad Sci 681:515–528PubMedCrossRefGoogle Scholar
  43. 43.
    Killen JA, Lindstrom JM (1984) Specific killing of lymphocytes that causes experimental autoimmune myasthenia gravis by ricin toxin-acetylcholine receptor conjugates. J Immunol 133:2549–2553PubMedGoogle Scholar
  44. 44.
    Sterz RK, Biro G, Filipp G et al (1985) Experimental autoimmune myasthenia gravis: can pretreatment with I-125-labeled receptor prevent functional damage at the neuromuscular iunction? J Immunol 134:841–846PubMedGoogle Scholar
  45. 45.
    Waldmann TA (1986) The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science 232:727–732PubMedCrossRefGoogle Scholar
  46. 46.
    Balcer LJ, McIntosh KR, Nichols JC et al (1991) Suppression of immune responses to acetylcholine receptor by interleukin-2 fusion toxin: in vivo and in vitro studies. J Neuroimmunol 31:115–122PubMedCrossRefGoogle Scholar
  47. 47.
    Weiner HL, Zhang ZJ, Khoury SJ et al (1991) Antigen-driven peripheral immune tolerance: suppression of organ-specific autoimmune diseases by oral administration of autoantigens. Ann NY Acad Sci 636:227–232PubMedCrossRefGoogle Scholar
  48. 48.
    Wang ZY, Qiao J, Link H (1993) Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. J Neuroimmunol 44:209–214PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1997

Authors and Affiliations

  • E. Facco
  • F. Gallo
  • S. M. Volpin

There are no affiliations available

Personalised recommendations